Navigation Links
Braces Work Wonders In Setting Crooked Teeth Right

An article in the January 2006 issue of AGD Impact, the newsmagazine of the Academy of General Dentistry (AGD), says that braces are the best way to correct crooked teeth. Orthodontics, the branch of dentistry,// which deals with crooked teeth is a great help in improving the "stability, function, and health of an individual’s teeth."

“Orthodontics can make people feel better about themselves,” said AGD spokesperson James G. Richeson, Jr., DDS, FAGD. “Many patients, prior to orthodontics, smile with their mouth closed, because they are self-conscious about their teeth, but after orthodontics, they usually smile naturally, showing off their new look.” Dentists usually feel the need for orthodontics to improve the appearance of the patient, correct problems like crooked or crowded teeth and incorrect jaw position, besides disorders of the jaw joint. “By age 7, a child will have started to get adult molars in place, and the position of these and the primary teeth provide the child’s general dentist with a good perspective of the development of the child’s dentition and any need for orthodontics,” said Dr. Richeson. Contact: Jaclyn Finneke Jaclyn.finneke@agd.org 312-440-4974 Academy of General Dentistry For more information visit http://www.agd.org/consumer/topics/orthodontics/braces.asp Source: Eurkalert
'"/>




Page: 1

Related medicine news :

1. Dental Braces Do Not Improve Self-esteem: Study
2. Flood Toll Rises, and Indonesia Braces for Disease
3. Setting up a new pharmaceutical industry in India
4. Setting Standards: Benchmark Medical Tests to Gauge Accuracy of Medical Tests
5. Indian PM Announces Of Setting Up India Study Center At Tashkent
6. B C Medical Association Reports on Setting Limits to Waiting Times
7. Colorectal Cancer Getting Missed Out in Office Setting
8. Crooked teeth may be due to evolution and overcooked meals
9. Genetic Dentistry: Your Dentist may be able to grow you a new set of Teeth.
10. Lost Teeth Could Signal Heart Problems
11. Wisdom Teeth: To Be Or Not To Be?
Post Your Comments:
(Date:12/5/2008)... Phyzoom provides physicians a...grow new business. , Colu...nounced today that it has launched Phase I of PHYZ...opment tools. For physicians, PHYZOOM offers nume... including detailed physician and practice profile...
(Date:12/4/2008)...N, Texas, Dec. 4 In the...to convince the world that a Red Ryder BB gun is t... out!" was the response he got from his parents, t...hilarious and memorable quotes from this Christmas...ing our childhood. And unfortunately, it comes tru...
(Date:12/4/2008)...ative research tracking people over a 20-year peri... , , THURSDAY, Dec. 4 (HealthDay News) -...appy friends of your friends. , That,s the unus...d people you,ve never met can have an impact on ea...ess spreads beyond people we,re directly connected...
(Date:12/4/2008)...NGTON, Dec. 4 The U.S. ...nal Development (USAID), is providing an additiona...Zimbabwe. This assistance is in addition to the $... program USAID is already implementing in Zimbabwe... was working alongside the international community...
Breaking Medicine News(10 mins):Health News:OnKua, Launches Phase I Of "Phyzoom" A Web-Based Physician Marketing And Customer Relationship Management Product 2Health News:OnKua, Launches Phase I Of "Phyzoom" A Web-Based Physician Marketing And Customer Relationship Management Product 3Health News:Texas Parents Can Prevent Holiday Tragedies with Safe Toys and Celebrations 2Health News:Being Happy Affects Even Those You Don't Know 2Health News:Being Happy Affects Even Those You Don't Know 3Health News:USAID Increases Assistance for Zimbabwe Cholera Outbreak 2
...ren, listed to go for surgeries, often depend on t...ich they take the crucial decision regarding the t...he August issue of Archives of Otolaryngology-Head...cheduled to undergo outpatient otolaryngology proc...
...old Spring Harbor laboratory have discovered that ...ess of aging. Similar versions of the gene are pr...wing parallels from mice, the researchers had conc...lay a fundamental biological role in aging-related...
...by Prosoy shows that Soy milks, yogurts and desser...le have become even more health-conscious and more...rchers say that based on the current trend sales a...t three years. According to the survey researchers...
...nts out that the difference in genes might be resp...ion deficit hyperactivity disorder (ADHD) differ i...he researchers from University of Illinois at Chic...riant form of a dopamine transporter gene -- a var...
Other Medicine News:Health News:Internet Helps Patients In Finding Info About Their Children's' Health Conditions 2
(Date:12/4/2008)...nist to Advance to Clinical Trials , , SAN ...als, Inc., a biopharmaceutical company focused on ...8) agonists for the treatment of cancer, respirato...t has initiated a Phase I clinical trial of VTX-23...cancer. The multi-center clinical trial is being ...
(Date:12/3/2008)...a demonstrating potential in newly diagnosed patie... featured in two oral sessions at ASH , , -...cally transfused patients by significantly reducin... - New long-term data from major independent breas...surgery treatment strategy, Femara vs. tamoxifen ,...
(Date:12/3/2008)...lleviates long-term anemia and organ damage in mic..., MEMPHIS, Tenn., Dec. 3 /PRNewswire-USNewswire... gene into mouse blood cells, scientists at St. Ju...ckle cell disease pathology. In their studies, the...sentially no difference from normal mice. Although...
(Date:12/3/2008)...Newswire/ -- Isogen, a contract development and,m...ounced it has retained a,strategic financial part...l,biopharma demand for Isogen,s services. , ...st round series of capital,investment and the ope... to,deliver on the previously unmet process, faci...
Breaking Medicine Technology:VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology 2More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 2More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 4More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 5More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 6More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 7More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 8More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 9More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 10More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 11More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 12More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 13More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 14More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 15More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 16More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 17More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 18More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 19More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 20More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 21More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 22Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3Are Muramyl Peptides the Magic Bullet in Probiotics 3F 1038 1Are Muramyl Peptides the Magic Bullet in Probiotics 3F 1038 2Are Muramyl Peptides the Magic Bullet in Probiotics 3F 1038 3With Obesity Diabetes and Cardiovascular Disease on the Rise Physicians Need More Comprehensive Guidelines 8040 1With Obesity Diabetes and Cardiovascular Disease on the Rise Physicians Need More Comprehensive Guidelines 8040 2SGI Introduces the SGI BioCluster Life Sciences Workflow Solution 8037 1SGI Introduces the SGI BioCluster Life Sciences Workflow Solution 8037 2SGI Introduces the SGI BioCluster Life Sciences Workflow Solution 8037 3SGI Introduces the SGI BioCluster Life Sciences Workflow Solution 8037 4InterCure Names Scot Dube Vice President of Sales 8034 1InterCure Names Scot Dube Vice President of Sales 8034 2InterCure Names Scot Dube Vice President of Sales 8034 3
...rgroupe Francophone du Myelome (IFM),Trial Present...PRNewswire-FirstCall/ --,Millennium Pharmaceutical...d on the comparative Phase III clinical trial eval...multiple myeloma (MM),patients. As induction thera...ELCADE based therapy produced a high complete remi...
...-- Ablynx today announced positive,interim results...pment programme, ALX-0081, an anti-thrombotic trea...cute; therapeutic,Nanobody® targeting von Will...thrombosis in patients with acute coronary,syndrom...signed to assess,safety, tolerability and pharmaco...
Other Medicine Technology:Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 2Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 3Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 4Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 5Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 6Ablynx Announces Interim Results of First Nanobody Phase I Study of,ALX-0081 (ANTI-VWF) 2
Soft PVC. Available in sizes 12-36F, Interior striations for smooth suction catheter insertion. Bevel tip. Single use. Sterile.
Smooth flexible medical grade white low density polyethylene with reinforced block to prevent collapse.
All oral and nasal airways are manufactured with smooth, rounded edges for increased patient comfort and safety., ,Portex® offers a broad selection of airways for a variety of clinical applicati
Black elastomer. Smooth finish. Non-Sterile.
Medicine Products: